The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy
Open accessThe DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Abstract
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, characterized by progressive inflammation and fibrosis of the bile ducts, resulting in biliary cirrhosis and is associated with a high risk of cholangiocarcinoma. The majority of patients are young, male and have coexisting inflammatory bowel disease. PSC is found with a prevalence of 10/100,000 in Northern European populations. The pathophysiology of PSC is a complex multistep process including immunological mechanisms, immunogenetic susceptibility and disorders of the biliary epithelia. The diagnosis is primarily based on endoscopic cholangiography although magnetic resonance imaging is increasingly used; biochemistry and immunoserology as well as histology play only a minor role. Due to the high risk of developing cholangiocarcinoma and also other tumours of the GI tract, surveillance strategies are essential, however they have yet to be established and evaluated. Biochemical parameters, clinical risk factors, endoscopic procedures and imaging techniques contribute to the early identification of patients at risk. Since medical therapy of PSC with ursodeoxycholic acid does not improve survival, to date, liver transplantation is the only option with a cure potential; if transplantation is accurately timed, transplanted PSC patients have an excellent rate of survival. However if cholangiocarcinoma is detected, a curative treatment is not possible in the majority of cases. The present review critically summarizes the current knowledge on the aetiopathogenesis of PSC and gives an overview of the diagnostic approaches, surveillance strategies and therapeutic options. Primary sclerosing cholangitis is a disease of unknown aetiology and without any further curative treatment options apart from liver transplantation. Therefore it may be regarded as the greatest challenge in hepatology today.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903 · cited 2×
“Cholangiographic classification system for primary sclerosing cholangitis (modified from [112,146])”
BackgroundMethodSelf-citationComplications of Endoscopic Biliary Sphincterotomy
Freeman, M. L., Nelson, D. B., Sherman, S., Haber, G. B., Herman, M. E., Dorsher, P. J., Moore, J. P., Fennerty, M. B., Ryan, M. E., Shaw, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351301 · Cited by 2,545 · cited 1×
“reported a 10% incidence of cholangitis in PSC patients [94–97].”
BackgroundChristakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290
Ulcerative Colitis and Colorectal Cancer: A Population-Based Study
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,777 · cited 1×
“A cancer incidence of approximately 9% and 30% after 20 and 30 years of disease has been reported [148].”
BackgroundMajor early complications from diagnostic and therapeutic ERCP: a prospective multicenter study
Loperfido, S., Angelini, G., Benedetti, G., Chilovi, F., Costan, F., De Berardinis, F., De Bernardin, M., Ederle, A., Fina, P., & Fratton, A. (1998) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(98)70121-x · Cited by 1,190 · cited 1×
“reported a 10% incidence of cholangitis in PSC patients [94–97].”
BackgroundComplications of diagnostic and therapeutic ERCP: a prospective multicenter study
Masci, E. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02387-x · Cited by 933
Kiesslich, R., Fritsch, J., Holtmann, M., Koehler, H. H., Stolte, M., Kanzler, S., Nafe, B., Jung, M., Galle, P. R., & Neurath, M. F. (2003) · Gastroenterology · doi:10.1053/gast.2003.50146 · Cited by 861 · cited 1×
“Chromoendoscopy and zoom colonoscopy might be helpful to unmask intraepithelial neoplasia and guide biopsy [155,156].”
BackgroundNatural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819 · cited 5×
“Predictive scores which have been developed to assess the progress of PSC in view of the clinical experiences of high interindividual variability and unpredictable acceleration episodes almost always contain serum bilirubin as a parameter [16,77,106,121,158,159].”
BackgroundResultInfluentialHepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717 · cited 5×
“2% [15–17].”
BackgroundInfluentialMolecular Pathogenesis of Cholestasis
Trauner, M., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 706 · cited 1×
“These transporters are differentially expressed on the sinusoidal and the canalicular membrane of hepatocytes and on biliary epithelial cells (BEC) [60].”
Background
Cited by
Pathogenesis of cholestatic liver disease and therapeutic approaches
Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.004 · Cited by 287
Tabibian, J. H., O'Hara, S. P., Trussoni, C. E., Tietz, P. S., Splinter, P. L., Mounajjed, T., Hagey, L. R., & LaRusso, N. F. (2016) · Hepatology · doi:10.1002/hep.27927 · Cited by 223
“In addition to and extending these associations is a growing number of studies suggesting that the intestinal microbiota plays an important pathophysiological role in PSC, hence providing the basis of the “leaky gut” hypothesis.(1,2) The focus of these studies, though, has been on the deleterious effects of microbial…”
BackgroundAutoantibodies in primary sclerosing cholangitis
Hov, J. R., Boberg, K. M., & Karlsen, T. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3781 · Cited by 187
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
Fosby, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i1.1 · Cited by 175
Characterization of animal models for primary sclerosing cholangitis (PSC)
Fickert, P., Pollheimer, M. J., Beuers, U., Lackner, C., Hirschfield, G., Housset, C., Keitel, V., Schramm, C., Marschall, H.-U., Karlsen, T. H., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.006 · Cited by 167
“The pathogenesis of PSC can be considered as enigmatic [10,11].”
Self-citationBarberio, B., Massimi, D., Cazzagon, N., Zingone, F., Ford, A. C., & Savarino, E. V. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.032 · Cited by 152
Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
Tabibian, J. H., Talwalkar, J. A., & Lindor, K. D. (2013) · BioMed Research International · doi:10.1155/2013/389537 · Cited by 91
Pregnancy in primary sclerosing cholangitis
Wellge, B. E., Sterneck, M., Teufel, A., Rust, C., Franke, A., Schreiber, S., Berg, T., Günther, R., Kreisel, W., zu Eulenburg, C., et al. (2011) · Gut · doi:10.1136/gut.2010.228924 · Cited by 76
Complications, symptoms, quality of life and pregnancy in cholestatic liver disease
Zakharia, K., Tabibian, A., Lindor, K. D., & Tabibian, J. H. (2018) · Liver International · doi:10.1111/liv.13591 · Cited by 42
Lenzen, H., Weismüller, T. J., Negm, A. A., Wlecke, J., Loges, S., Strassburg, C. P., Manns, M. P., & Lankisch, T. O. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.825313 · Cited by 11
“Primary sclerosing cholangitis (PSC) is a cholestatic liver disease of unknown origin, characterized by progressive inflammation of the intrahepatic and extrahepatic bile ducts, causing biliary strictures and eventually leading to biliary cirrhosis [1,2].”
BackgroundSelf-citation
Metadata
- Authors
- Weismüller, T. J., Wedemeyer, J., Kubicka, S., Strassburg, C. P., & Manns, M. P.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2008
- Volume
- 48
- Pages
- S38-S57
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2015585189
- Cited by
- 164
- References
- 195
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.